Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Share Purchase Plan

25 Jan 2021 07:00

RNS Number : 6774M
Impellam Group plc
25 January 2021
 

25 January 2021

Impellam Group plc

("Impellam" or the "Company")

Share Purchase Plan

The Company announces it has entered into a trading plan (the "Share Purchase Plan") to buy back shares for cancellation. The Share Purchase Plan will commence with immediate effect and will, unless terminated at an earlier date, expire on the date of the Company's next Annual General Meeting, when the Company will reconfirm its intentions.

Under the Share Purchase Plan, the Company will instruct its broker, Canaccord Genuity Limited, to acquire ordinary shares of 1 pence each in the Company ("Ordinary Shares"). Purchases of Ordinary Shares under the Share Purchase Plan will be limited to ÂŁ0.5 million of Ordinary Shares (by market value) per calendar month up to the date of the Company's next Annual General Meeting, currently due to be held on 29 June 2021.

The maximum price paid for such Ordinary Shares shall be an amount equal to the higher of (i) 5% above the average of the middle market quotations for the Ordinary Shares as derived from the London Stock Exchange's Daily Official List for the five business days prior to making any purchase; and (ii) the higher of the price of the last independent trade of and the highest current independent bid for an Ordinary Share on the London Stock Exchange's AIM market.

Notwithstanding the average daily volume restrictions set out in Article 3(3) (b) of the Commission Delegated Regulation (EU) 2016/1052, the Company may make purchases in excess of these volume restrictions, subject to prevailing market conditions and liquidity.

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

Note to Editors:

Impellam is the second largest1 staffing company in the UK and sixth largest2 Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit: www.impellam.com 

1 By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts. Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGZMGFDGMZM
Date   Source Headline
22nd Dec 201710:12 amRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSTransaction in Own Shares
18th Dec 20177:00 amRNSShare Purchase Plan
15th Nov 20173:38 pmRNSTrading Statement
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20174:51 pmRNSDirectorate Change
27th Jul 20177:00 amRNSHalf-year Report
28th Jun 201710:49 amRNSResult of AGM
28th Apr 20172:12 pmRNSDirector/PDMR Shareholding
16th Mar 20175:09 pmRNSAnnual Financial Report & Dividend Record Date
9th Mar 20177:00 amRNSPreliminary Results - Unaudited
15th Dec 20167:00 amRNSTrading Update
28th Jul 20167:00 amRNSHalf-year Report
29th Jun 20169:31 amRNSResult of AGM
5th May 20167:00 amRNSQ1 Trading Update
7th Apr 201611:16 amRNSHolding(s) in Company
5th Apr 20163:21 pmRNSIssue of Equity
30th Mar 20162:11 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSDividend Record Date
3rd Mar 20167:00 amRNSPreliminary Results - Unaudited
12th Jan 20168:19 amRNSTrading update and joint broker - replacement
12th Jan 20167:00 amRNSTrading update and appointment of joint broker
14th Dec 201512:15 pmRNSDirector/PDMR Shareholding
11th Dec 20158:01 amRNSTotal Voting Rights
8th Dec 20157:00 amRNSAcquisition and Trading Update
16th Nov 201511:35 amRNSResult of General Meeting
30th Oct 20157:00 amRNSPosting of Circular and Notice of General Meeting
27th Oct 20155:25 pmRNSProposed change in nature of Dividend
2nd Sep 20157:00 amRNSGrant of Options
30th Jul 20157:00 amRNSHalf Yearly Report
13th Jul 20159:00 amRNSPosting of circular
30th Jun 201510:04 amRNSResult of AGM
4th Jun 20157:00 amRNSNotice of AGM and change to dividend timetable
17th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 20154:35 pmRNSIssue of Equity & Director's Shareholding
6th Mar 20159:00 amRNSAnnual Financial Report
3rd Mar 20157:00 amRNSPreliminary Results - Unaudited
16th Jan 20157:00 amRNSPre-Close Trading Update
12th Jan 20157:00 amRNSDirectorate Change
16th Dec 201410:30 amRNSDirectorate Change
13th Nov 20147:30 amRNSHolding(s) in Company
10th Nov 20141:03 pmRNSCompletion of Acquisition and Directorate Change
7th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20148:00 amRNSDirectors' Dealings
4th Nov 20147:10 amRNSPlacing to raise £15 million
4th Nov 20147:00 amRNSAcquisition of Lorien
30th Jul 20147:00 amRNSHalf Yearly Report
18th Jun 20143:44 pmRNSResult of AGM
15th May 20144:00 pmRNSDeath of a Director
7th May 20147:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.